Ameriprise’s Nutex Health NUTX Stock Holding History

Ameriprise’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21M	Buy	7,070 +93	+1%	+$11.8K	﹤0.01%	3321
2026 Q1	$663K	Sell	6,977 -54	-0.8%	-$6.62K	﹤0.01%	3472
2025 Q4	$1.16M	Buy	+7,031	New	+$933K	﹤0.01%	3266

Other funds holding NUTX

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Ameriprise's NUTX Position: Q2 2026 in Review

Ameriprise increased its Nutex Health (NUTX) stake by 1.3% in Q2 2026, buying an estimated $11.8K and bringing the position to 7,070 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3321.

Ameriprise first reported a position in NUTX in Q4 2025 and has held it in 3 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

Ameriprise held 7,070 shares of Nutex Health worth $1.21M as of Q2 2026.
Ameriprise bought 93 Nutex Health shares in Q2 2026, an estimated $11.8K.
Nutex Health made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3321 holding.
Ameriprise first reported a position in Nutex Health in Q4 2025 and has held it in 3 quarters since.
154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.